Rare lephants
Screener

Xenon Pharmaceuticals Inc.

XENE ·Healthcare, Drug Manufacturers - General
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
S-8 POS Jun 3, 2026 S-8 POS
S-8 POS Jun 3, 2026 S-8 POS
S-8 POS Jun 3, 2026 S-8 POS
S-8 POS Jun 3, 2026 S-8 POS
S-8 POS Jun 3, 2026 S-8 POS
S-8 POS Jun 3, 2026 S-8 POS
S-8 POS Jun 3, 2026 S-8 POS
S-8 POS Jun 3, 2026 S-8 POS
S-8 POS Jun 3, 2026 S-8 POS
S-8 Jun 3, 2026 S-8
8-K Jun 3, 2026 8-K
SCHEDULE 13G/A May 15, 2026
SCHEDULE 13G/A May 15, 2026
SCHEDULE 13G/A May 15, 2026
4 May 13, 2026 4
10-Q May 7, 2026 10-Q
8-K May 7, 2026 8-K
ARS Apr 22, 2026 ARS
DEFA14A Apr 22, 2026 DEFA14A
DEF 14A Apr 22, 2026 DEF 14A
S-8 Apr 13, 2026 S-8
8-K Apr 13, 2026 8-K
4 Mar 13, 2026 4
4 Mar 13, 2026 4
4 Mar 13, 2026 4
← Newer Page 2 of 32 · 799 filings Older →